---
document_datetime: 2025-12-29 07:40:46
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/tasermity.html
document_name: tasermity.html
version: success
processing_time: 0.0989436
conversion_datetime: 2025-12-30 11:48:28.638981
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Tasermity

[RSS](/en/individual-human-medicine.xml/66332)

##### Lapsed

This medicine's authorisation has lapsed

sevelamer hydrochloride Medicine Human Lapsed

On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [News on Tasermity](#news-on)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 26 February 2015, the marketing authorisation of Tasermity (sevelamer) ceased to be valid in the European Union (EU). The cessation of validity is due to the fact that the marketing authorisation holder, Genzyme Europe BV, had not marketed Tasermity in the EU since its initial marketing authorisation.

In accordance with provisions of the sunset clause, the marketing authorisation of the medicinal product lapsed as the product had not been marketed in any of the EU Member States within three years of its initial authorisation. Tasermity was granted marketing authorisation in the EU on 26 February 2015 for the control of hyperphosphataemia in adult patients receiving haemodialysis or peritoneal dialysis. Tasermity is an identical product to Renagel, which remains authorised in the EU.

The European Public Assessment Report (EPAR) for Tasermity is updated accordingly to reflect the fact that the marketing authorisation is no longer valid.

Tasermity : EPAR - Summary for the public

Reference Number: EMA/150836/2015

English (EN) (542.02 KB - PDF)

**First published:** 09/04/2015

**Last updated:** 27/03/2018

[View](/en/documents/overview/tasermity-epar-summary-public_en.pdf)

[Other languages (22)](#file-language-dropdown-724)

български (BG) (625.29 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/bg/documents/overview/tasermity-epar-summary-public_bg.pdf)

español (ES) (540.75 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/es/documents/overview/tasermity-epar-summary-public_es.pdf)

čeština (CS) (606.31 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/cs/documents/overview/tasermity-epar-summary-public_cs.pdf)

dansk (DA) (539.65 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/da/documents/overview/tasermity-epar-summary-public_da.pdf)

Deutsch (DE) (543.09 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/de/documents/overview/tasermity-epar-summary-public_de.pdf)

eesti keel (ET) (539.14 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/et/documents/overview/tasermity-epar-summary-public_et.pdf)

ελληνικά (EL) (630.2 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/el/documents/overview/tasermity-epar-summary-public_el.pdf)

français (FR) (545.91 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/fr/documents/overview/tasermity-epar-summary-public_fr.pdf)

hrvatski (HR) (562.68 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/hr/documents/overview/tasermity-epar-summary-public_hr.pdf)

italiano (IT) (539.32 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/it/documents/overview/tasermity-epar-summary-public_it.pdf)

latviešu valoda (LV) (605.39 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/lv/documents/overview/tasermity-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (566.96 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/lt/documents/overview/tasermity-epar-summary-public_lt.pdf)

magyar (HU) (600.14 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/hu/documents/overview/tasermity-epar-summary-public_hu.pdf)

Malti (MT) (608.98 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/mt/documents/overview/tasermity-epar-summary-public_mt.pdf)

Nederlands (NL) (541.06 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/nl/documents/overview/tasermity-epar-summary-public_nl.pdf)

polski (PL) (606.59 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/pl/documents/overview/tasermity-epar-summary-public_pl.pdf)

português (PT) (541.22 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/pt/documents/overview/tasermity-epar-summary-public_pt.pdf)

română (RO) (566.63 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/ro/documents/overview/tasermity-epar-summary-public_ro.pdf)

slovenčina (SK) (606.04 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/sk/documents/overview/tasermity-epar-summary-public_sk.pdf)

slovenščina (SL) (596.67 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/sl/documents/overview/tasermity-epar-summary-public_sl.pdf)

Suomi (FI) (539.62 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/fi/documents/overview/tasermity-epar-summary-public_fi.pdf)

svenska (SV) (540.84 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/sv/documents/overview/tasermity-epar-summary-public_sv.pdf)

## Product information

Tasermity : EPAR - Product Information

English (EN) (736.7 KB - PDF)

**First published:** 09/04/2015

**Last updated:** 27/03/2018

[View](/en/documents/product-information/tasermity-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-563)

български (BG) (1.19 MB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/bg/documents/product-information/tasermity-epar-product-information_bg.pdf)

español (ES) (796.79 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/es/documents/product-information/tasermity-epar-product-information_es.pdf)

čeština (CS) (1.04 MB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/cs/documents/product-information/tasermity-epar-product-information_cs.pdf)

dansk (DA) (661.84 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/da/documents/product-information/tasermity-epar-product-information_da.pdf)

Deutsch (DE) (676.81 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/de/documents/product-information/tasermity-epar-product-information_de.pdf)

eesti keel (ET) (724.78 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/et/documents/product-information/tasermity-epar-product-information_et.pdf)

ελληνικά (EL) (1.2 MB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/el/documents/product-information/tasermity-epar-product-information_el.pdf)

français (FR) (736.19 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/fr/documents/product-information/tasermity-epar-product-information_fr.pdf)

hrvatski (HR) (837.41 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/hr/documents/product-information/tasermity-epar-product-information_hr.pdf)

íslenska (IS) (899.61 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/is/documents/product-information/tasermity-epar-product-information_is.pdf)

italiano (IT) (600.14 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/it/documents/product-information/tasermity-epar-product-information_it.pdf)

latviešu valoda (LV) (1.07 MB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/lv/documents/product-information/tasermity-epar-product-information_lv.pdf)

lietuvių kalba (LT) (862.73 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/lt/documents/product-information/tasermity-epar-product-information_lt.pdf)

magyar (HU) (1 MB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/hu/documents/product-information/tasermity-epar-product-information_hu.pdf)

Malti (MT) (1.09 MB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/mt/documents/product-information/tasermity-epar-product-information_mt.pdf)

Nederlands (NL) (726.85 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/nl/documents/product-information/tasermity-epar-product-information_nl.pdf)

norsk (NO) (802.35 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/no/documents/product-information/tasermity-epar-product-information_no.pdf)

polski (PL) (1.24 MB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/pl/documents/product-information/tasermity-epar-product-information_pl.pdf)

português (PT) (697.43 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/pt/documents/product-information/tasermity-epar-product-information_pt.pdf)

română (RO) (824.82 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/ro/documents/product-information/tasermity-epar-product-information_ro.pdf)

slovenčina (SK) (1.02 MB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/sk/documents/product-information/tasermity-epar-product-information_sk.pdf)

slovenščina (SL) (976.85 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/sl/documents/product-information/tasermity-epar-product-information_sl.pdf)

Suomi (FI) (771.65 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/fi/documents/product-information/tasermity-epar-product-information_fi.pdf)

svenska (SV) (604.97 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/sv/documents/product-information/tasermity-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** N/0006 15/12/2017

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Tasermity : EPAR - All Authorised presentations

English (EN) (465.73 KB - PDF)

**First published:** 09/04/2015

**Last updated:** 27/03/2018

[View](/en/documents/all-authorised-presentations/tasermity-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-348)

български (BG) (512.77 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/bg/documents/all-authorised-presentations/tasermity-epar-all-authorised-presentations_bg.pdf)

español (ES) (462.79 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/es/documents/all-authorised-presentations/tasermity-epar-all-authorised-presentations_es.pdf)

čeština (CS) (504.22 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/cs/documents/all-authorised-presentations/tasermity-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (462.4 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/da/documents/all-authorised-presentations/tasermity-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (462.42 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/de/documents/all-authorised-presentations/tasermity-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (462.47 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/et/documents/all-authorised-presentations/tasermity-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (512.93 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/el/documents/all-authorised-presentations/tasermity-epar-all-authorised-presentations_el.pdf)

français (FR) (462.45 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/fr/documents/all-authorised-presentations/tasermity-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (491.64 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/hr/documents/all-authorised-presentations/tasermity-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (462.34 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/is/documents/all-authorised-presentations/tasermity-epar-all-authorised-presentations_is.pdf)

italiano (IT) (462.52 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/it/documents/all-authorised-presentations/tasermity-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (505.33 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/lv/documents/all-authorised-presentations/tasermity-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (492.57 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/lt/documents/all-authorised-presentations/tasermity-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (503.22 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/hu/documents/all-authorised-presentations/tasermity-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (504.62 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/mt/documents/all-authorised-presentations/tasermity-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (462.29 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/nl/documents/all-authorised-presentations/tasermity-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (462.2 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/no/documents/all-authorised-presentations/tasermity-epar-all-authorised-presentations_no.pdf)

polski (PL) (489.12 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/pl/documents/all-authorised-presentations/tasermity-epar-all-authorised-presentations_pl.pdf)

português (PT) (462.65 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/pt/documents/all-authorised-presentations/tasermity-epar-all-authorised-presentations_pt.pdf)

română (RO) (491.42 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/ro/documents/all-authorised-presentations/tasermity-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (503.71 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/sk/documents/all-authorised-presentations/tasermity-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (487.67 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/sl/documents/all-authorised-presentations/tasermity-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (462.33 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/fi/documents/all-authorised-presentations/tasermity-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (462.42 KB - PDF)

**First published:**

09/04/2015

**Last updated:**

27/03/2018

[View](/sv/documents/all-authorised-presentations/tasermity-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Tasermity Active substance sevelamer hydrochloride International non-proprietary name (INN) or common name sevelamer hydrochloride Therapeutic area (MeSH)

- Hyperphosphatemia
- Renal Dialysis

Anatomical therapeutic chemical (ATC) code V03AE02

### Pharmacotherapeutic group

All other therapeutic products

### Therapeutic indication

Tasermity is indicated for the control of hyperphosphataemia in adult patients receiving haemodialysis or peritoneal dialysis. Sevelamer hydrochloride should be used within the context of a multiple therapeutic approach, which could include calcium supplements, 1,25 dihydroxy Vitamin D3 or one of its analogues to control the development of renal bone disease.

## Authorisation details

EMA product number EMEA/H/C/003968 Marketing authorisation holder

Genzyme Europe BV

Paasheuvelweg 25

Marketing authorisation issued 25/02/2015 Lapse of marketing authorisation 26/02/2015 Revision 4

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Tasermity : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (548.5 KB - PDF)

**First published:** 12/09/2016

**Last updated:** 27/03/2018

[View](/en/documents/procedural-steps-after/tasermity-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

Tasermity-H-C-PSUSA-2697-201510 : EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Reference Number: EMA/CHMP/571186/2016

English (EN) (533.73 KB - PDF)

**First published:** 12/09/2016

**Last updated:** 27/03/2018

[View](/en/documents/scientific-conclusion/tasermity-h-c-psusa-2697-201510-epar-scientific-conclusions-and-grounds-variation-terms-marketing-authorisation_en.pdf)

## Initial marketing authorisation documents

Tasermity : EPAR - Public assessment report

Adopted

Reference Number: EMA/CHMP/68384/2015

English (EN) (628.16 KB - PDF)

**First published:** 09/04/2015

**Last updated:** 27/03/2018

[View](/en/documents/assessment-report/tasermity-epar-public-assessment-report_en.pdf)

CHMP summary of positive opinion for Tasermity

Adopted

Reference Number: EMA/CHMP/761518/2014

English (EN) (530.16 KB - PDF)

**First published:** 19/12/2014

**Last updated:** 27/03/2018

[View](/en/documents/smop-initial/chmp-summary-positive-opinion-tasermity_en.pdf)

#### News on Tasermity

[Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 15-18 December 2014](/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-15-18-december-2014) 19/12/2014

**This page was last updated on** 27/03/2018

## Share this page

[Back to top](#main-content)